Latest news
The Merger Paradox: Why Transformational Mergers Create Extraordinary Value and Frequently Fail - Pharmaceutical ExecutivePharmaceutical Executive · Fri, 07 Aug 2026 10:07:38 GMTBeyond the Megamerger: How Rumored AstraZeneca–BMS Discussions Signal a New Era of Pharmaceutical Competition - Pharmaceutical ExecutivePharmaceutical Executive · Wed, 05 Aug 2026 15:17:36 GMTInside Pharma's Patent Battleground: The Policy Changes Reshaping Generic and Biosimilar Competition - Pharmaceutical ExecutivePharmaceutical Executive · Tue, 04 Aug 2026 23:02:22 GMTCourt upholds CMA findings that firms charged excessive and unfair prices for lifesaving NHS-funded medicine - GOV.UKGOV.UK · Tue, 28 Jul 2026 07:00:00 GMT